Financial reports
10-K
2023 FY
Annual report
12 Mar 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
16 May 23
NT 10-Q
Notice of late quarterly filing
11 May 23
10-K
2022 FY
Annual report
31 Mar 23
NT 10-K
Notice of late annual filing
16 Mar 23
10-Q
2022 Q3
Quarterly report
21 Nov 22
NT 10-Q
Notice of late quarterly filing
16 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
Current reports
8-K
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
12 Mar 24
8-K
Entry into a Material Definitive Agreement
19 Jan 24
8-K
Departure of Directors or Certain Officers
12 Jan 24
8-K
Bioventus Names Robert Claypoole as President and Chief Executive Officer
21 Dec 23
8-K
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
7 Nov 23
8-K
Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
8 Aug 23
8-K
Departure of Directors or Certain Officers
9 Jun 23
8-K
Bioventus Completes Divestiture of its Wound Business
26 May 23
8-K
Bioventus Reports First Quarter Financial Results
16 May 23
8-K
Bioventus Announces Divestiture of its Wound Business
16 May 23
Registration and prospectus
S-8
Registration of securities for employees
20 Mar 24
S-8
Registration of securities for employees
9 Jan 24
S-8
Registration of securities for employees
16 Jun 23
S-8
Registration of securities for employees
18 Apr 23
S-8
Registration of securities for employees
1 Apr 22
S-8
Registration of securities for employees
11 Mar 22
S-8
Registration of securities for employees
29 Oct 21
425
Business combination disclosure
18 Oct 21
424B3
Prospectus supplement
24 Sep 21
Other
EFFECT
Notice of effectiveness
27 Sep 21
CORRESP
Correspondence with SEC
22 Sep 21
UPLOAD
Letter from SEC
14 Sep 21
SEC STAFF
SEC staff action: Order
12 Feb 21
CERT
Certification of approval for exchange listing
11 Feb 21
EFFECT
Notice of effectiveness
11 Feb 21
CORRESP
Correspondence with SEC
10 Feb 21
UPLOAD
Letter from SEC
9 Feb 21
CORRESP
Correspondence with SEC
8 Feb 21
CORRESP
Correspondence with SEC
8 Feb 21
Ownership
4
Mark Leonard Singleton
15 Apr 24
4
Anthony D'Adamio
15 Apr 24
4
KATRINA J CHURCH
15 Apr 24
4
Mark Leonard Singleton
12 Apr 24
4
Anthony D'Adamio
12 Apr 24
4
KATRINA J CHURCH
12 Apr 24
144
Notice of proposed sale of securities
11 Apr 24
144
Notice of proposed sale of securities
11 Apr 24
144
Notice of proposed sale of securities
11 Apr 24
144
Notice of proposed sale of securities
27 Mar 24